A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Phase 1 Completed 69 enrolled Supernus Pharmaceuticals, Inc.

NaSingle-groupOpen-labelTreatment

Summary

This multi-center, two-treatment study compares the pharmacokinetic profiles of Immediate Release (IR) and Modified Release (MR) formulations of Topiramate (TPM) in patients with epilepsy.

Timeline

Start: 2010-06
Primary completion: 2010-12
Completion: 2011-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Topiramate	Small molecule	—	—

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Summary

Timeline

Drugs

Indications